Get the Stockscreener App
26.17
5.06%
1.26
Kestra Medical Technologies Ltd stock is traded at $26.17, with a volume of 414.62K.
It is up +5.06% in the last 24 hours and down -2.31% over the past month.
Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.
See More
Previous Close:
$24.91
Open:
$26.45
24h Volume:
414.62K
Relative Volume:
1.32
Market Cap:
$1.53B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+8.72%
1M Performance:
-2.31%
6M Performance:
+39.54%
1Y Performance:
+0.00%
1-Day Range:
$24.32
$27.18
1-Week Range:
$23.46
$27.18
52-Week Range:
$13.25
$30.00
Kestra Medical Technologies Ltd Stock (KMTS) Company Profile
Name
Kestra Medical Technologies Ltd
Sector
Industry
Phone
(425) 279-8002
Address
3933 LAKE WASHINGTON BLVD NE, KIRKLAND
Compare KMTS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KMTS
Kestra Medical Technologies Ltd
|
26.17 | 1.45B | 0 | 0 | 0 | 0.00 |
|
ISRG
Intuitive Surgical Inc
|
542.32 | 194.04B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
200.89 | 57.21B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
78.80 | 38.69B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
252.27 | 36.84B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
267.56 | 19.61B | 2.96B | 487.70M | 344.00M | 6.6758 |
Kestra Medical Technologies Ltd Stock (KMTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-18-25 | Initiated | BTIG Research | Buy |
| Mar-31-25 | Initiated | BofA Securities | Buy |
| Mar-31-25 | Initiated | Goldman | Neutral |
| Mar-31-25 | Initiated | Piper Sandler | Overweight |
| Mar-31-25 | Initiated | Stifel | Buy |
| Mar-31-25 | Initiated | Wells Fargo | Overweight |
| Mar-31-25 | Initiated | Wolfe Research | Outperform |
View All
Kestra Medical Technologies Ltd Stock (KMTS) Latest News
Kestra Medical Technologies (NASDAQ:KMTS) Shares Gap UpHere's What Happened - MarketBeat
Kestra Medical Technologies (KMTS) Q2: Revenue Growth, Losses Deepen, Testing Bullish Scale Narratives - simplywall.st
Wells Fargo Maintains Kestra Medical Technologies (KMTS) Overweight Recommendation - Nasdaq
Kestra Medical Technologies’ revenue up 53% to USD 22.6M in Q2 FY26 - Medical Buyer
Kestra Medical Technologies, Ltd. $KMTS Position Increased by Eventide Asset Management LLC - MarketBeat
Kestra Medical Technologies Reports Strong Earnings Growth - TipRanks
Wells Fargo Raises Price Target for KMTS, Maintains Overweight R - GuruFocus
Kestra Medical Technologies stock price target raised by Stifel to $30 - Investing.com Australia
Kestra Medical Technologies stock price target raised to $30 from $27 at Piper Sandler - Investing.com India
Kestra Medical price target raised to $30 from $27 at Piper Sandler - TipRanks
Kestra Medical Technologies: Strong Financial Performance and Market Leadership Drive Buy Rating - TipRanks
Kestra raises FY26 revenue guidance to $91M while targeting 70%+ gross margins with ASSURE system expansion - MSN
Is Kestra Medical Technologies Ltd a good long term investmentSector Performance Drivers & High Return Trading Strategies - earlytimes.in
Kestra Medical Technologies Ltd (KMTS) Q2 2026 Earnings Call Highlights: Revenue Surge and ... By GuruFocus - Investing.com Canada
Earnings call transcript: Kestra Medical Technologies Q2 2025 shows strong revenue growth - Investing.com Australia
Kestra Medical raises FY26 revenue view to $91M from $88M, consensus $88.02M - TipRanks
Kestra Medical (KMTS) Q2 2026 Earnings Transcript - The Globe and Mail
Kestra Medical Technologies plunges 11% as quarterly loss exceeds estimates - Investing.com
Kestra Medical Technologies Q2 2026 Earnings Call Transcript - MarketBeat
KESTRA MEDICAL TECHNOLOGIES, LTD. SEC 10-Q Report - TradingView — Track All Markets
Kestra Medical reports Q2 EPS (64c), consensus (57c) - TipRanks
Kestra Medical Fiscal Q2 Loss Narrows, Revenue Rises; Fiscal 2026 Revenue Outlook Lifted - marketscreener.com
Kestra Medical Technologies plunges 11% as quarterly loss exceeds estimates By Investing.com - Investing.com South Africa
Kestra Medical Technologies Reports Second Quarter Fiscal 2026 Financial Results - TradingView — Track All Markets
Earnings Flash (KMTS) Kestra Medical Technologies, Ltd. Reports Q2 Revenue $22.6M, vs. FactSet Est of $20.7M - marketscreener.com
Kestra Medical Technologies announces public offering of common shares - MSN
A&O Shearman advised on Kestra Medical Technologies upsized USD158.7 million follow-on equity offering - A&O Shearman
Earnings To Watch: Kestra Medical Technologies Ltd (KMTS) Reports Q2 2025 Result - GuruFocus
Archimedes Vascular Announces Close of Series A Financing led by Sherpa Healthcare Partners and Appoints Raymond W. Cohen as Chairman of its Board of Directors - Quantisnow
Kestra Medical Technologies, Ltd. $KMTS Shares Sold by Omega Fund Management LLC - MarketBeat
Brown Advisory Inc. Increases Position in Kestra Medical Technologies, Ltd. $KMTS - Defense World
Assessing Kestra Medical Technologies (KMTS) Valuation After Its Recent Share Price Pullback - Yahoo Finance
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Kestra Medical prices upsized $138M offering - MSN
Kestra Medical Raises $148.4 Million in Public Offering - TipRanks
Kestra Medical Technologies (NASDAQ:KMTS) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
Can Kestra Medical Technologies Ltd. stock withstand economic slowdown2025 Sector Review & Safe Entry Point Alerts - Newser
Kestra Medical Technologies (KMTS): Assessing a 20x Sales Valuation After a Recent Double-Digit Daily Gain - simplywall.st
Will Kestra Medical Technologies Ltd. stock see PE expansionEarnings Miss & Consistent Profit Trading Strategies - Newser
Form 424B4 KESTRA MEDICAL TECHNOLOG - StreetInsider
Kestra Medical Technologies (Nasdaq: KMTS) sets Dec. 11 call to discuss Q2 fiscal 2026 results - Stock Titan
Kestra Medical Technologies, Ltd. to Report Second Quarter Fiscal 2026 Financial Results - marketscreener.com
Kestra Medical Technologies Prices Upsized Offering of 6 Million Shares - marketscreener.com
Kestra Medical Technologies prices upsized public offering at $23 per share By Investing.com - Investing.com South Africa
Kestra Medical Technologies prices upsized public offering at $23 per share - Investing.com Australia
KMTS FinancialsIncome Statement - Quiver Quantitative
Kestra Medical says co prices upsized primary public offering of 6 million shares at $23 per share - marketscreener.com
Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Primary Public Offering of Common Shares - MarketScreener
Kestra Medical Technologies Ltd Stock (KMTS) Financials Data
There is no financial data for Kestra Medical Technologies Ltd (KMTS). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.32%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):